Lucas Svetlana

Director at Jasper Therapeutics, Inc. · on record since Jun 20, 2024
Director at aTYR PHARMA INC · on record since May 13, 2026
Director at LIFELINE SYSTEMS CO · on record since Jul 2, 2019
Chief Business Officer at Scribe Therapeutics, Inc. · on record since Jul 23, 2026

Insider trading activity of Lucas Svetlana

Transactions on record: 19; since Jul 2, 2019

Open-market buys: 2; $93.6K

Open-market sells: 0

Companies traded: 4; last filing Aug 4, 2026

Figures computed from official regulatory filings — .

Companies where Lucas Svetlana has traded

Jasper Therapeutics, Inc.5 tx · $48.6K · Aug 4, 2026
Scribe Therapeutics, Inc.4 tx · $45K · Jul 27, 2026
aTYR PHARMA INC2 tx · May 13, 2026
LIFELINE SYSTEMS CO8 tx · May 23, 2024

Track record of Lucas Svetlana

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lucas Svetlana

Co-insiders of Lucas Svetlana

Church Jill MarieaTYR PHARMA INC +1
Coughlin Timothy PaTYR PHARMA INC +1
EcoR1 Capital Fund Qualified, L.P.aTYR PHARMA INC +1
Gross Jane AaTYR PHARMA INC +1
Krueger NancyaTYR PHARMA INC +1
SCHIMMEL PAULaTYR PHARMA INC +1
Shukla SanjayaTYR PHARMA INC +1
Zaknoen SaraaTYR PHARMA INC +1
Abingworth Bioventures VII LPJasper Therapeutics, Inc.
Abingworth LLPJasper Therapeutics, Inc.
Accel Growth Fund IV Associates L.L.C.LIFELINE SYSTEMS CO
Accel Growth Fund IV L.P.LIFELINE SYSTEMS CO

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Jasper Therapeutics, Inc.Listing on record	Aug 4, 2026	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Scribe Therapeutics, Inc.Listing unverified	Jul 27, 2026	Buy	3,000	15.00 USD	$45K	conv 64	SEC
Scribe Therapeutics, Inc.Listing unverified	Jul 27, 2026	AwardD (derivative)	109,426	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Scribe Therapeutics, Inc.Listing unverified	Jul 27, 2026	AwardD (derivative)	9,547	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Scribe Therapeutics, Inc.Listing unverified	Jul 27, 2026	AwardD (derivative)	109,426	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
aTYR PHARMA INCListing on record	May 13, 2026	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jasper Therapeutics, Inc.Listing on record	Sep 24, 2025	Buy	20,000	2.43 USD	$48.6K	conv 83ClusterFirst in 12mo	SEC
Jasper Therapeutics, Inc.Listing on record	Sep 24, 2025	BuyD (derivative)	20,000	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Jasper Therapeutics, Inc.Listing on record	Jul 3, 2025	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
aTYR PHARMA INCListing on record	May 2, 2025	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jasper Therapeutics, Inc.Listing on record	Jun 20, 2024	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	May 23, 2024	AwardD (derivative)	24,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	May 19, 2023	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	Apr 28, 2023	Exercise	6,000	—	n/a (No price was disclosed in the filing)		SEC
LIFELINE SYSTEMS COListing unverified	Apr 28, 2023	ExerciseD (derivative)	-6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	Apr 28, 2022	AwardD (derivative)	6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	Apr 29, 2021	AwardD (derivative)	1,428	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	May 8, 2020	AwardD (derivative)	1,428	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	Jul 2, 2019	AwardD (derivative)	2,285	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Jasper Therapeutics, Inc.Listing on record	Aug 4, 2026	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Scribe Therapeutics, Inc.Listing unverified	Jul 27, 2026	Buy	3,000	15.00 USD	$45K	conv 64	SEC
Scribe Therapeutics, Inc.Listing unverified	Jul 27, 2026	AwardD (derivative)	109,426	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Scribe Therapeutics, Inc.Listing unverified	Jul 27, 2026	AwardD (derivative)	9,547	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Scribe Therapeutics, Inc.Listing unverified	Jul 27, 2026	AwardD (derivative)	109,426	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
aTYR PHARMA INCListing on record	May 13, 2026	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jasper Therapeutics, Inc.Listing on record	Sep 24, 2025	Buy	20,000	2.43 USD	$48.6K	conv 83ClusterFirst in 12mo	SEC
Jasper Therapeutics, Inc.Listing on record	Sep 24, 2025	BuyD (derivative)	20,000	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Jasper Therapeutics, Inc.Listing on record	Jul 3, 2025	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
aTYR PHARMA INCListing on record	May 2, 2025	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jasper Therapeutics, Inc.Listing on record	Jun 20, 2024	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	May 23, 2024	AwardD (derivative)	24,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	May 19, 2023	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	Apr 28, 2023	Exercise	6,000	—	n/a (No price was disclosed in the filing)		SEC
LIFELINE SYSTEMS COListing unverified	Apr 28, 2023	ExerciseD (derivative)	-6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	Apr 28, 2022	AwardD (derivative)	6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	Apr 29, 2021	AwardD (derivative)	1,428	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	May 8, 2020	AwardD (derivative)	1,428	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LIFELINE SYSTEMS COListing unverified	Jul 2, 2019	AwardD (derivative)	2,285	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC